Treatment with PDE5 inhibitors not associated with reduced risk for AD, dementia

Treatment with sildenafil or tadalafil was not associated with a reduced risk for incident Alzheimer’s disease and related dementia in patients with pulmonary hypertension, according to a study published in Brain Communications.
“In recent years, there has been significant interest in using computational biology-based approaches to identify novel drug repurposing candidates for [Alzheimer’s disease and related dementia],” Rishi J. Desai, MS, PhD, assistant professor of medicine at Harvard Medical School and associate epidemiologist at Brigham and Women’s Hospital,

Treatment with sildenafil or tadalafil was not associated with a reduced risk for incident Alzheimer’s disease and related dementia in patients with pulmonary hypertension, according to a study published in Brain Communications.
“In recent years, there has been significant interest in using computational biology-based approaches to identify novel drug repurposing candidates for [Alzheimer’s disease and related dementia],” Rishi J. Desai, MS, PhD, assistant professor of medicine at Harvard Medical School and associate epidemiologist at Brigham and Women’s Hospital,